Fortitude Family Office’s Immunome IMNM Stock Holding History

Fortitude Family Office’s Portfolio IMNM Stock Details IMNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.29K	Hold	60	–	–	﹤0.01%	2156
2026 Q2	$1.27K	Hold	60	–	–	﹤0.01%	1665
2026 Q1	$1.31K	Hold	60	–	–	﹤0.01%	1430
2025 Q4	$1.29K	Hold	60	–	–	﹤0.01%	1358
2025 Q3	$703	Hold	60	–	–	﹤0.01%	1675
2025 Q2	$558	Buy	+60	New	+$492	﹤0.01%	1748

Other funds holding IMNM

MWM

Maltin Wealth Management Ridgewood, New Jersey $308M AUM 16.5% 1-Year Est. Return

GWM

GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Fortitude Family Office's IMNM Position: Q3 2026 in Review

Fortitude Family Office held its Immunome (IMNM) position steady in Q3 2026 at 60 shares worth $1.29K. The position accounts for ﹤0.01% of the portfolio, ranked #2156.

Fortitude Family Office first reported a position in IMNM in Q2 2025 and has held it in 6 quarters since. The position peaked at $1.31K in Q1 2026. 6 funds tracked by Wall St. Rank hold IMNM as of Q3 2026.

Fortitude Family Office held 60 shares of Immunome worth $1.29K as of Q3 2026.
Fortitude Family Office left its Immunome share count unchanged in Q3 2026.
Immunome made up ﹤0.01% of Fortitude Family Office's portfolio in Q3 2026, its #2156 holding.
Fortitude Family Office first reported a position in Immunome in Q2 2025 and has held it in 6 quarters since.
Fortitude Family Office's Immunome position peaked at $1.31K in Q1 2026.
6 funds tracked by Wall St. Rank held Immunome as of Q3 2026.

Based on Fortitude Family Office's 13F filing for Q3 2026, filed 14 Oct 2026.